NPI: 1265747752 · OWENSBORO, KY 42303 · Physician Assistant · NPI assigned 08/09/2010
Authorized official RANALLO, RUSSELL controls 20+ related entities in our dataset. Read more
| Authorized Official | RANALLO, RUSSELL (SECRETARY) |
| NPI Enumeration Date | 08/09/2010 |
Other providers sharing the same authorized official: RANALLO, RUSSELL
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 5,000 | $161K |
| 2019 | 9,765 | $317K |
| 2020 | 10,826 | $391K |
| 2021 | 12,404 | $352K |
| 2022 | 12,523 | $326K |
| 2023 | 10,132 | $315K |
| 2024 | 7,515 | $282K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 99213 | Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 33,450 | 31,194 | $926K |
| 99214 | Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 11,815 | 11,204 | $504K |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | 3,070 | 2,703 | $270K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 6,064 | 5,767 | $79K |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | 466 | 418 | $66K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 2,372 | 2,255 | $64K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 3,103 | 2,894 | $43K |
| 45385 | Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) | 208 | 189 | $43K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 1,034 | 987 | $22K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 804 | 753 | $22K |
| 99204 | Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 214 | 209 | $17K |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | 170 | 154 | $17K |
| 99443 | 186 | 166 | $9K | |
| 99442 | 213 | 197 | $8K | |
| 99215 | Prolong outpt/office vis | 149 | 137 | $7K |
| 99232 | Subsequent hospital care, per day, moderate complexity | 285 | 164 | $7K |
| 99222 | Initial hospital care, per day, moderate complexity | 119 | 107 | $6K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 181 | 174 | $6K |
| 71046 | Radiologic examination, chest; 2 views | 496 | 477 | $5K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 62 | 61 | $4K |
| 99203 | Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 64 | 59 | $3K |
| 45378 | Colonoscopy, flexible; diagnostic, including collection of specimen(s) | 14 | 14 | $3K |
| 99231 | Subsequent hospital care, per day, straightforward or low complexity | 165 | 104 | $3K |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 1,401 | 1,305 | $2K |
| 43237 | 16 | 14 | $2K | |
| 43248 | 12 | 12 | $1K | |
| 99254 | 17 | 15 | $1K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 658 | 613 | $669.57 |
| 74328 | 30 | 25 | $575.43 | |
| 81002 | 1,290 | 1,228 | $461.94 | |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | 12 | 12 | $457.23 |
| 91200 | 12 | 12 | $113.49 | |
| 81025 | 13 | 13 | $81.00 |